No Increased Risk of irAEs Seen After COVID-19 Vaccination in Patients on ICIs
Patients with lung cancer who underwent COVID-19 vaccination while receiving immune checkpoint inhibitors did not have an increased risk of immune-related adverse events.
Diagnosis & Disease Information
Vaccines Estimated to Have Prevented 19.8 Million COVID-19 Deaths
More deaths would have been averted had vaccine coverage targets from COVAX and WHO been met, according to researchers.
Predicting Response to COVID-19 Vaccines in Patients With Hematologic Malignancies
Two treatment-related factors and the frequency of 6 cell types were associated with response to COVID-19 vaccination.
Dexamethasone Increases Risk for Superinfections in Patients With Severe COVID-19
Researchers assessed the association between dexamethasone treatment and the occurrence of superinfections among patients with severe COVID-19.
COVID-19 Vaccine Candidate Nanocovax Induces Robust Immunity
Researchers assessed the safety and immunogenicity of Nanocovax, a novel COVID-19 vaccine candidate.
One in Nine May Get Delayed Large Local Reaction After Moderna Vaccine
There was a higher risk for DLLR seen among women and among individuals aged 30 to 69 years.
CML Does Not Affect Antibody Development Against SARS-CoV-2
Investigators reported findings from the ongoing SARS2 SeroPrevalence And Respiratory Tract Assessment (SPARTA) study.
Lower Risk of COVID-19 in Infants With Vaccination During Pregnancy
Infants of mothers who received a second or third dose of a COVID-19 vaccine during pregnancy had a lower risk of COVID-19 during the first 4 months of life.
COVID-19 Vaccines Most Effective in Patients With Myeloma and Gastrointestinal, Lung Cancers
A leukemia or lymphoma diagnosis was tied to lower vaccine effectiveness.
Three-Dose Pfizer Vaccine Spurs Strong Response in Youngest Children
The third dose gave the young children 80% protection against asymptomatic COVID-19, the company says.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...